Degree

Manhattan Unveils First Unified Commerce Benchmark for Specialty Retail in Europe

Retrieved on: 
Tuesday, March 5, 2024

Manhattan Associates Inc. (NASDAQ: MANH) today announced the findings of the industry's first real-world analysis of Unified Commerce in specialty retail in Europe conducted in partnership with Google Cloud and Zebra Technologies.

Key Points: 
  • Manhattan Associates Inc. (NASDAQ: MANH) today announced the findings of the industry's first real-world analysis of Unified Commerce in specialty retail in Europe conducted in partnership with Google Cloud and Zebra Technologies.
  • The Unified Commerce Benchmark for Specialty Retail, conducted by Incisiv via actual shopping transactions, assessed three retail verticals (apparel and footwear, home and DIY, and luxury), and five countries (France, Germany, Italy, UK, and the Netherlands).
  • The Unified Commerce Benchmark for Specialty Retail in Europe conducted by Incisiv , assessed 50 retailers, analysing 290+ customer experience capabilities in four categories including: search and discovery; cart and checkout; promising and fulfilment and service and support.
  • Of the 50 retailers benchmarked, four brands emerged as overall leaders in Unified Commerce: Adidas, H&M, Leroy Merlin and M&S.

60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer

Retrieved on: 
Thursday, February 8, 2024

WASHINGTON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP ; SXTPW) (“60P” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today it has appointed Kristen Landon to the newly created role of Chief Commercial Officer, effective immediately.

Key Points: 
  • WASHINGTON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP ; SXTPW) (“60P” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today it has appointed Kristen Landon to the newly created role of Chief Commercial Officer, effective immediately.
  • Ms. Landon is an accomplished commercial leader with over 26 years’ experience launching, building, and transforming commercial teams and brands in the pharmaceutical industry.
  • “We screened hundreds of applicants during the second half of 2023 and Kristen’s vision and directly relevant experience made her the ideal match for the position,” said Geoff Dow, PhD., 60 Degrees Pharma Chief Executive Officer.
  • Ms. Landon holds an MBA from Silberman College of Business at Fairleigh Dickinson University, and a Bachelor’s degree from Kean University.

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

Retrieved on: 
Wednesday, January 31, 2024

WASHINGTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the closing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.

Key Points: 
  • WASHINGTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the closing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.
  • Each Unit consists of one share of common stock and one warrant exercisable for one share of common stock (the “Warrant”).
  • The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.
  • The gross proceeds to the Company from the offering were approximately $2.4 million, before deducting underwriter fees and other offering expenses payable by the Company.

60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering

Retrieved on: 
Tuesday, January 30, 2024

WASHINGTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the pricing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.

Key Points: 
  • WASHINGTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the pricing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.
  • Each Unit consists of one share of common stock and one warrant exercisable for one share of common stock (the “Warrant”).
  • The closing of the offering is expected to occur on or about January 31, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from the offering are expected to be approximately $2.4 million, before deducting underwriter fees and other offering expenses payable by the Company.

Longeveron Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease

Retrieved on: 
Wednesday, December 20, 2023

The expanded data set reinforced the earlier top-line findings showing that the primary safety endpoint was met and provided further support for Lomecel-B’s positive benefit/risk profile.

Key Points: 
  • The expanded data set reinforced the earlier top-line findings showing that the primary safety endpoint was met and provided further support for Lomecel-B’s positive benefit/risk profile.
  • Wa’el Hashad, CEO of Longeveron, commented: “These new data support our initial results for CLEAR MIND that we announced in October and provide further validation of both the safety and therapeutic potential of Lomecel-B™ in the treatment of mild Alzheimer’s disease.
  • In addition to these clinical findings, brain imaging showed improvement in brain architecture measured by volumetric MRI and DTI, respectively.
  • Taken together, the Company believes the results of the CLEAR MIND study build a strong foundation for further development in mild Alzheimer's disease patients.

98 Degrees Reveals New Album With Pre-order Exclusively on TalkShopLive

Retrieved on: 
Thursday, December 14, 2023

LAS VEGAS, Dec. 14, 2023 /PRNewswire/ -- The legendary boy band 98 Degrees has partnered exclusively with TalkShopLive, the leading live commerce platform, to announce the pre-order of their highly anticipated new album.  The album, featuring five re-recorded Greatest Hits and five brand new tracks, includes the ballad and first single, "Got U," and marks the group's first new music release in several years. Fans can now purchase signed copies of the vinyl version of the album in an exclusive orange crush color on TalkShopLive. CDs are also available. Watch and shop here: https://talkshop.live/watch/8HX7b4n-WR1T

Key Points: 
  • LAS VEGAS, Dec. 14, 2023 /PRNewswire/ -- The legendary boy band 98 Degrees has partnered exclusively with TalkShopLive , the leading live commerce platform, to announce the pre-order of their highly anticipated new album.
  • Fans can now purchase signed copies of the vinyl version of the album in an exclusive orange crush color on TalkShopLive.
  • 98 Degrees recently celebrated its 25th anniversary with a successful sold-out tour this past fall.
  • Nick Lachey, Jeff Timmons, Justin Jeffre and Drew Lachey will also answer your questions and chat with fans LIVE!

LEADING HEALTHCARE AND EDUCATION EXPERT HARRIS PASTIDES JOINS HUB INTERNATIONAL AS STRATEGIC INDUSTRY ADVISOR

Retrieved on: 
Thursday, November 9, 2023

CHICAGO, Nov. 9, 2023 /PRNewswire/ -- Hub International Limited (HUB), a leading global insurance brokerage, announced today that Harris Pastides has joined as Strategic Industry Advisor.

Key Points: 
  • CHICAGO, Nov. 9, 2023 /PRNewswire/ -- Hub International Limited (HUB), a leading global insurance brokerage, announced today that Harris Pastides has joined as Strategic Industry Advisor.
  • "Harris has a strong reputation as a leading industry expert in healthcare and education," said Chris Treanor, HUB President of Programs & Specialties.
  • Pastides serves on several boards, chairs the Fulbright Program's Council for the International Exchange of Scholars and is on the Executive Committee of the Institute for International Education.
  • Pastides earned a Master of Public Health and PhD in Epidemiology from Yale University.

Coursera Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, October 26, 2023

Coursera, Inc. (NYSE: COUR) today announced financial results for its third quarter ended September 30, 2023.

Key Points: 
  • Coursera, Inc. (NYSE: COUR) today announced financial results for its third quarter ended September 30, 2023.
  • For more information regarding the non-GAAP financial measures discussed in this press release, please see "Non-GAAP Financial Measures" and "Reconciliation of GAAP to Non-GAAP Financial Measures" below.
  • We have provided a reconciliation of GAAP to non-GAAP financial measures in the financial statement tables for our historical non-GAAP financial results included in this press release.
  • As previously announced, Coursera will hold a conference call to discuss its third quarter 2023 performance today, October 26, 2023, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

St. George's University and Seneca Polytechnic announce new partnership

Retrieved on: 
Tuesday, October 10, 2023

program

Key Points: 
  • program
    TRUE BLUE, Grenada and TORONTO, Oct. 10, 2023 /CNW/ - St. George's University has launched a new partnership with Seneca Polytechnic that will offer qualified Seneca students fast-track status and expedited entry into the five- or six-year M.D.
  • "Seneca Polytechnic offers students a first-rate education," said Dr. Marios Loukas, Dean of St. George's University School of Medicine .
  • "We're delighted to form this partnership with Seneca and welcome its graduates to St. George's to launch their careers in medicine."
  • Students may apply for the special admissions pathways to St. George's when applying to or while enrolled at Seneca.

33 Degrees Convenience Connect Selects Vengo as Its Exclusive Programmatic Seller

Retrieved on: 
Thursday, September 21, 2023

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- 33 Degrees Convenience Connect (“33 Degrees”), a leader in convenience store media, today announced its partnership with Vengo™, the leading place-based media technology and sales platform.

Key Points: 
  • NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- 33 Degrees Convenience Connect (“33 Degrees”), a leader in convenience store media, today announced its partnership with Vengo™, the leading place-based media technology and sales platform.
  • Vengo will monetize 33 Degrees’ network through programmatic sales and private marketplace transactions.
  • 33 Degrees’ clients have seen substantial lift in sales through many case studies.
  • “From a consumer’s viewshed, the 33 Degrees screens have a similar impact to large format digital roadside billboards brought indoors to the point-of-purchase,” said Brian Shimmerlik, Co-Founder & CEO at Vengo.